Opioid pharmacotherapy: barriers to treatment


Angelo Pricolo examines the main reasons patients cease, or don't access, therapies for opioid dependence... and why many pharmacies don't offer it We know that about 50,000 people in Australia currently receive either methadone or buprenorphine to treat their opioid dependence. We estimate that as many as that figure again could potentially be candidates for

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Check: do neckties reduce blood supply to the brain?
Next Natural cold and flu remedies: not to be sniffed at!